JRJill Alexandra Rabinowitz

Jill Alexandra Rabinowitz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jill Alexandra Rabinowitz has a total of 258 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A phenome-wide association study of externalizing polygenic risk in the Adolescent Brain Cognitive Development (ABCD) study

    by Sarah E. Paul, Nathaniel Thomas, Maia Choi, Nastasia S. Courchesne-Krak, I-Tzu Hung, Travis T. Mallard, Nicole R. Karcher, Aaron J. Gorelik, Genevieve F. Dash, John Meredith, et al.

    Background: Externalizing disorders encompass a range of disinhibited behaviors that typically manifest in youth and are linked with adverse psychological and social outcomes. Polygenic liability to externalizing behaviors has been associated with psychiatric and disease phenotypes in adults. Identifying correlates of genetic risk in youth—prior to the emergence of more impairing manifestations of externalizing behaviors (e.g. substance use disorders)—could improve our etiological understanding and inform targeted prevention efforts. Methods: We conducted a phenome-wide association study (PheWAS) to test whether externalizing (EXT) polygenic scores (PGS) were associated with up to 1,697 psychosocial, behavioral, environmental, and health-related phenotypes among youth of European-like genetic ancestry. PheWAS data came from the baseline ( n = 4,931, mean age = 9.93 ± 0.63 years, 46.9% female) and two-year follow-up ( n = 4,507, 12.02 ± 0.66 years, 47.0% female) data collection waves of the Adolescent Brain Cognitive Development Study SM (ABCD Study®). Secondary analyses examined within-family effects and moderation by biological sex. Results: EXT PGS was associated with 268 and 352 phenotypes at baseline and follow-up, respectively, following Bonferroni correction at each wave. The strongest associations were observed with externalizing behaviors, screen time/media use, caffeine consumption, sleep disturbances, and poor school performance. Effects were attenuated by 59%–64% within family, on average, with five predominantly externalizing phenotypes remaining significantly associated with within-family PGS. There was limited evidence of moderation by biological sex. Conclusions: These results broadly characterize the early phenotypic correlates of an externalizing polygenic score and can be used to generate hypotheses about phenotypes that might represent mechanisms or future prevention targets.

  • Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation

    by Kellyn M. Spychala, Christina E. Garasky, Margaret L. Clapp Sullivan, Emma C. Johnson, Jodi Kutzner, Dongbing Lai, Zeal Jinwala, Alex P. Miller, Danielle M. Dick, Jill A. Rabinowitz, et al.

    Background: The widespread prevalence of alcohol use disorder (AUD) and availability of treatments contrasts with limited treatment utilization. Here, in the Collaborative Studies on the Genetics of Alcoholism (COGA), we examined the extent to which genetic factors (i.e., family‐based heritability ( h 2 GCTA ), polygenic scores [PGS]) are associated with individual differences in AUD treatment utilization that could be leveraged to target intervention efforts. Methods: Non‐proband COGA participants with a lifetime Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM‐5) AUD diagnosis, whose genomic ancestry resembled that of European (EUR‐like: N = 3148; 370 nuclear families; 222 extended family pedigrees) and African (AFR‐like: N = 962; 92 nuclear families; 79 extended family pedigrees) reference panels were selected for analyses. AUD treatment h 2 GCTA and associations with PGS (i.e., alcohol involvement, cigarette use, psychopathology, externalizing behavior, and cognition‐related) were estimated, along with between‐ and within‐family effects of the PGSs. Results: AUD treatment was heritable ( h 2 GCTA = 0.36; SE = 0.06) and positively associated with PGS for problematic alcohol use, drinks/week, externalizing behavior, depression, anxiety and schizophrenia/bipolar (ORs > 1.12) while being negatively associated with education attainment (OR = 0.90) in the EUR‐like sample after accounting for AUD severity ( p FDR ≤ 0.04). When all significant PGSs were simultaneously included, only alcohol PGSs remained significant. There were no significant PGS associations in within‐family analyses. Despite a nominally significant positive association with cigarettes per day, no PGSs were associated with AUD treatment following FDR adjustment in the AFR‐like sample. Conclusions: Genetic factors underlying alcohol use influence AUD treatment utilization, but this phenotype is largely not significantly associated with current estimates of polygenic scores for other complex traits; this suggests a potential unique genetic etiology requiring further investigation with a genome‐wide association study. The lack of significant within‐family PGS associations may have likely arisen from power reductions due to restricting the sample to full siblings. Together, these findings highlight potential facets influencing the underutilization of AUD treatment.

  • Open Access

    Psychiatric and substance use disorder polygenic scores are associated with the exposome in youth

    by I.-Tzu Hung, Nathaniel S. Thomas, David W. Sosnowski, Julia W. Felton, Ran Barzilay, Tyler M. Moore, Elina Visoki, Nathan A. Gillespie, Danielle M. Dick, Brion S. Maher, et al.

    Gene-environment correlations (rGE) present challenges for accurately estimating the individual and joint contributions of genetic and environmental influences on risk for psychiatric and substance use disorders. The present study examined rGE between polygenic risk scores (PGS) for psychiatric and substance use disorders and environmental exposures (i.e., exposome factors) using multi-level data spanning youth- and parent-reports, as well as objective measures of the built environment. Participants included 4,797 genetically similar to European reference populations, 1,585 genetically similar to African reference populations, and 2,012 genetically similar to Admixed American reference populations from the Adolescent Brain and Cognitive Development (ABCD) Study. The ABCD study was conducted at 21 sites across the U.S and used a stratified probability sampling design to ensure the cohort recruited was demographically diverse. Based on factor-analytic work conducted by Moore et al. (2022) in the ABCD study, the exposome included 6 factors: household adversity, neighborhood adversity, positive day-to-day experiences, state conservatism/ruralness, family values, and pregnancy/birth complications. Disorder-specific PGS for psychiatric (e.g., major depressive disorder, attention deficit hyperactivity disorder) and substance use conditions (e.g., alcohol use disorders, cannabis use disorders), as well as PGS for common liability for externalizing and general substance use disorders, were used to examine genetic associations with the exposome factors. After adjusting for participant sex, age, log income-to-needs ratio, and genetic ancestry principal components, higher PGS for psychiatric (e.g., broad externalizing liability, attention deficit hyperactivity disorder) and substance use disorders (e.g., general substance use disorders, cannabis use disorder) were positively associated with household adversity and negatively associated with positive day-to-day experiences. Our results indicate that polygenic risk for psychiatric and substance use disorders correlate with environmental factors in adolescence at multiple levels, most notably household adversity and positive day-to-day experiences. Findings underscore the importance of investigating rGE when examining these environmental exposures with genetic risk for psychiatric and substance use disorders.

  • Links of fitbit-derived sleep architecture and fragmentation with ADHD symptoms and externalizing behaviors in adolescents

    by Charlotte Clapham, I-Tzu Hung, Nicole Tacugue, Brion S. Maher, Vadim Zipunnikov, Joe Kossowsky, Jill A. Rabinowitz

  • Association of vitamin D and B12 levels with actigraphic sleep in cognitively unimpaired middle-aged and older adults

    by Diefei Chen, Jill A Rabinowitz, Fan Wu, Zhikui Wei, Yang An, Jennifer A Schrack, Toshiko Tanaka, Chee W Chia, Mark N Wu, Sarah K Wanigatunga, et al.

    Background: Low vitamin D and B12 levels are linked to low self-reported sleep quality and conditions comorbid with sleep disturbances in older adults. We examined the associations between serum vitamin D and B12 levels with actigraphic sleep indices in middle-aged and older adults. Methods: We studied 460 participants aged 40 and older (70.9 ± 12.0 [SD] years; 52.8% female; 22.2% Black) in the Baltimore Longitudinal Study of Aging. Predictors included total serum vitamin D and B12, sleep outcomes included total sleep time (TST, minutes), sleep efficiency (SE, %), sleep onset latency (minutes), wake after sleep onset (WASO, minutes), and average wake bout length (WBL, minutes). We examined race and sex as effect modifiers of associations between vitamins and sleep. Results: Higher vitamin D concentration was associated with longer TST (B = 23.63 minutes, 95% CI, 9.62-37.64) and shorter WBL (B = −0.29 minutes, 95% CI, −0.50 to −0.09). Vitamin D deficiency was associated with shorter TST (B= −23.03 minutes, 95% CI, −42.05 to −4.01). The associations between vitamin D and sleep were stronger among Black participants. Higher B12 was associated with shorter WASO in women but longer WASO in men. B12 insufficiency/deficiency was associated with longer TST in men but shorter TST in women. Conclusions: Higher vitamin D levels are associated with longer and less disturbed sleep in middle-aged and older adults. Future studies are needed to understand if maintaining optimal vitamin D levels improve sleep quality and promote better sleep-associated health outcomes.

  • Open Access

    Associations of Accelerometry-Derived Time in Major Activity Intensities with Cognitive Outcomes: A Compositional Data Analysis Approach

    by Daniel Callow, Jill A Rabinowitz, Xinkai Zhou, Xiaowen Chen, Ryan Dougherty, Ciprian Crainiceanu, Lacey Etzkorn, Amal A Wanigatunga, Sarah K Wanigatunga, Adam P Spira, et al.

    Background: Physical activity (PA), sedentary behavior (SB), and sleep are modifiable lifestyle factors linked to cognitive health. Prior research has largely relied on self-report to measure these constructs or ignored the compositional nature of these data. We applied compositional data analysis (CoDA) to quantify the association between accelerometry-derived measures of time in major activity domains and cognitive outcomes among older adults. Methods: Participants were 927 older adults (M age = 82.71 years, SD = 3.99, range = 76-95) from the Atherosclerosis Risk in Communities (ARIC) study who wore wrist-worn accelerometers and completed cognitive assessments. Major activity domains were time in bed and time out of bed, which were divided into four categories: sedentary behavior (SB), low-light (low-LIPA), high-light (high-LIPA), and moderate-to-vigorous physical activity (MVPA). Cognitive outcomes included global cognition, memory, executive function, and language performance. Results: Across all cognitive domains, greater time spent in MVPA relative to other activity domains, including out-of-bed time, sedentary behavior, and low-LIPA, was associated with better cognitive performance. In contrast, greater time spent in low-LIPA relative to other activity domains was consistently associated with poorer performance across all cognitive domains, and these associations were attenuated, but remained statistically significant, after adjustment for gait speed. Sedentary behavior was negatively associated with executive function only. Conclusions: The trade-off between time spent in MVPA and in low-LIPA is the objectively measured physical activity that was most strongly associated with cognitive abilities. Time spent in low-LIPA may be an important biomarker of physical health and cognitive impairment.

  • Open Access

    The Contributions of Multiple Polygenic Scores in Predicting Liability for Major Depressive Disorder and Its Comorbidity with Alcohol Use Disorder

    by Jonathan L. Wells, Jill A. Rabinowitz, Brion S. Maher, Amanda E. Gentry, James B. Burch, Elizabeth C. Prom-Wormley

    The inclusion of polygenic scores (PGS) from genetically correlated traits such as Major Depressive Disorder (MDD) and alcohol use disorder (AUD) may improve the prediction of these outcomes and their comorbidity. Despite the importance of this work, few studies have evaluated the efficacy of this possibility. The current study evaluates the use of MDD and AUD PGS individually and together to improve the prediction of MDD, AUD, and comorbid MDD-AUD using a sample of European, African, or Admixed American Ancestry participants from the National Longitudinal Study of Adolescent to Adult Health ( N = 7,965). Cross-ancestry MDD and AUD PGS were created using PRS-CSx. The best fitting model of comorbid MDD-AUD in the whole sample included PGS for MDD and AUD (PGS MDD OR: 1.26, 95% CI 1.16–1.35, p = 2.69 × 10 − 6 ; PGS AUD OR: 1.77, 95% CI 1.66–1.87, p = 3.49 × 10 − 28 ), explaining an additional 4.88% of variance compared to a model only including sociodemographic covariates. For MDD, the best fitting model included the MDD PGS (OR: 1.25, 95% CI 1.17–1.33, p = 2.05 × 10 − 8 ), explaining an additional 0.65% of variance. For AUD, the best fitting model included the AUD PGS (OR: 1.37, 95% CI 1.32–1.43, p = 1.25 × 10 −28 ), which explained an additional 1.52% of variance. Inclusion of both PGS did not significantly improve the prediction of individual MDD or AUD. Inclusion of PGS for MDD and AUD significantly improved prediction for comorbid MDD-AUD, but not in MDD or AUD. These results help clarify the role of utilizing genetically correlated PGS in improving prediction of MDD, AUD, and comorbid MDD-AUD.

  • Open Access

    Perceived partner substance use, genetic predispositions, and their associations with problematic alcohol use, emotional well-being, and relationship quality

    by Megan E. Cooke, Sally I-Chun Kuo, Erin Lumpe, Fazil Aliev, Sarah J. Brislin, Kathleen K. Bucholz, Grace Chan, Danielle M. Dick, Howard J. Edenberg, Chella Kamarajan, et al.

    Background: Romantic relationships are important contexts for substance use and emotional well-being. We tested the hypotheses that (i) genetic predispositions for alcohol consumption would be positively associated with partner substance use, (ii) partner substance use would moderate genetic influences on one’s own alcohol outcomes, and (iii) partner discordance in substance use would be associated with lower emotional well-being and relationship quality. Methods: Analyses included 2,357 participants (M age = 51.4, 58.2% female) from the Collaborative Studies on the Genetics of Alcoholism. Focal measures included participants’ reports of their own and their current partner’s past-year substance use (frequencies of alcohol use, heavy drinking, drunkenness, cannabis use, and nicotine use), emotional well-being, and relationship quality. Participants’ genetic predispositions were indexed with genome-wide polygenic scores for alcohol consumption (PGS Alc ). Participant–partner substance use discordance was calculated as the difference between the participant’s and their partner’s use for each substance use measure, separately. Results: Participant PGS Alc was not significantly associated with partners’ perceived substance use. Frequent perceived partner alcohol use and heavy drinking significantly amplified the association between PGS Alc and alcohol use or drunkenness. Frequent perceived partner drunkenness and cannabis use significantly attenuated the association between PGS Alc and heavy drinking or frequency of alcohol use. Participant–partner discordance for several substance use measures was significantly associated with lower emotional well-being and relationship quality, controlling for participant and partner substance use main effects. Conclusions: The results highlight the importance of partner substance use in etiological models of alcohol use, emotional health outcomes, and relationship quality.

  • Open Access

    Correction: Associations of personality traits with actigraphic sleep in middle-aged and older adults

    by Jill A. Rabinowitz, Yijun Zhou, Diefei Chen, Yiwei Yue, Darlynn M. Rojo-Wissar, Yang An, Sarah Wanigatunga, Jennifer A. Schrack, Vadim Zipunnikov, Eleanor M. Simonsick, et al.

  • Open Access

    Household Adversity, Day to Day Experiences, and Birth/Pregnancy Complications are Associated with Delay Discounting: Findings from the Adolescent Brain Cognitive Development Study

    by I-Tzu Hung, Nathaniel S. Thomas, Brett Gelino, Justin C. Strickland, Ran Barzilay, Tyler M. Moore, Elina Visoki, Brion Maher, Julia W. Felton, Jill A. Rabinowitz

    Delay discounting, or the propensity to devalue rewards as the time to reward receipt increases, is a robust predictor of psychiatric and neurodevelopmental outcomes across the life course. However, less is known about environmental antecedents that may be associated with delay discounting tendencies during adolescence, a developmental period during which delay discounting behaviors are still developing. Here, we examined the relation between delay discounting and the exposome—multi-level environmental exposures experienced from conception onwards. Participants included 9,848 children (Mage = 10.94 years, SD = 0.64; 53.2% female; 72% White) from the Adolescent Brain Cognitive Development Study who completed the Adjusting Delay Discounting Task at the 1-year follow-up. Predictors included six exposome factors that captured aspects of proximal and distal environments including: positive day-to-day experiences, family values, household adversity, neighborhood poverty, birth/pregnancy complications, and state-level conservatism/rurality. Greater household adversity, lower positive day-to-day experiences, and greater birth/pregnancy complications were associated with greater delay discounting, after adjusting for age, sex, race, household income and parent education. These findings highlight potential intervention and policy targets aimed at modifying delay discounting preferences in adolescence and reducing risk for negative sequelae across development.